Cassava Sciences, Inc. FLNA
0.75
(0.02)
(2.60%)
as of 25 Sep
- Market cap
- $37.8M
- P/E
- 0.0×
Follow FLNA
Insider Buys
alert about insiders buying in the last 12 month
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
28.68 | 9.42 | 39.22 | 16.83 | 50.40 | 19.51 | 29.91 | 9.13 | 11.62 | 2.23 |
Net Debt/EBITDA |
1.26 | 0.88 | 3.00 | 4.71 | 14.56 | 7.22 | 2.55 | 1.16 | 0.92 | 1.01 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.82 | 0.69 | 0.73 | 0.54 | 0.85 | 0.93 | 1.02 | 0.84 | 4.80 | 0.35 |
Capex/Depreciation |
(1.29) | 0.00 | 0.00 | (0.31) | 16.36 | (41.60) | (2.08) | (0.27) | (0.09) | (0.62) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (61.87%) | (84.07%) | (44.72%) | (22.20%) | (11.08%) | (18.71%) | (31.67%) | (53.27%) | (17.19%) | (82.66%) | |
| (57.99%) | (79.06%) | (42.34%) | (21.23%) | (10.76%) | (17.94%) | (30.40%) | (50.31%) | (15.75%) | (65.95%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (100.31%) | (188.56%) | (405.48%) | (516.08%) | 0.00% |
Return on Tangible Assets |
(79.68%) | (122.96%) | (33.43%) | (21.04%) | (6.87%) | (12.82%) | (33.58%) | (70.81%) | (16.70%) | (122.08%) |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(1.89) | (1.26) | (0.45) | (0.15) | (0.19) | (1.33) | (2.00) | (1.97) | (2.53) | (0.68) |
Cash per Share |
2.87 | 1.60 | 1.85 | 1.33 | 3.58 | 5.92 | 5.00 | 2.89 | 2.78 | 1.98 |
Shareholders Equity per Share |
2.86 | 1.48 | 1.84 | 1.27 | 3.53 | 6.44 | 5.66 | 3.28 | 3.15 | 1.54 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2.86 | 1.48 | 1.84 | 1.27 | 3.53 | 6.44 | 5.66 | 3.28 | 3.15 | 1.54 |
Free Cash Flow |
(12.31) | (8.24) | (4.77) | (2.53) | (5.02) | (52.41) | (80.23) | (82.44) | (117.03) | (32.83) |
Working Capital |
18.41 | 9.53 | 19.53 | 21.96 | 92.13 | 231.95 | 204.16 | 115.44 | 124.78 | 53.88 |
Capital Expenditures |
(0.07) | — | — | (0.02) | 0.36 | (22.21) | (2.71) | (0.41) | (0.10) | (0.58) |
Net Current Asset Value |
18.41 | 9.53 | 19.53 | 21.96 | 91.89 | 231.62 | 203.93 | 115.44 | 124.70 | 53.76 |
| Other line items | ||||||||||
Quick Ratio |
28.14 | 9.26 | 38.76 | 16.64 | 50.14 | 18.62 | 28.46 | 8.53 | 10.94 | 2.18 |
Depreciation/Fixed assets |
0.25 | 0.44 | 0.79 | 1.23 | 2.00 | 0.03 | 0.06 | 0.07 | 0.05 | 0.05 |
Cash ROIC |
(33.38%) | (41.59%) | (12.32%) | (5.67%) | (2.90%) | (10.43%) | (23.42%) | (40.17%) | (50.29%) | (31.13%) |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(1.88) | (1.26) | (0.45) | (0.14) | (0.21) | (0.77) | (1.93) | (1.96) | (2.52) | (0.67) |
Capex per Share |
(0.01) | 0.00 | 0.00 | 0.00 | 0.01 | (0.56) | (0.07) | (0.01) | 0.00 | (0.01) |
Average Payables |
0.67 | 0.36 | 0.36 | 0.37 | 0.68 | 4.02 | 5.57 | 7.30 | 9.11 | 24.65 |
Average Assets |
25.61 | 15.07 | 15.49 | 21.81 | 58.89 | 180.54 | 250.81 | 193.25 | 154.60 | 137.94 |
Average Common Equity |
24.00 | 14.17 | 14.66 | 20.86 | 57.15 | 173.06 | 240.73 | 182.50 | 141.59 | 110.05 |
Capex to Sales |
0.00 | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates